Cancer Statistics - Karmanos Cancer Institute

More documents

Recommendations

Info

African-American <strong>Cancer</strong> Incidence, Mortality and Age Adjusted Rates per 100,000 Population by Site, Race and Sex, Metropolitan Detroit, 2004 12 African-American Incidence Rate Mortality Rate Total Male Female Total Male Female Total Male Female Total Male Female All Sites (Invasive) 4,614 2,465 2,149 537.5 712.8 422.3 1,930 999 931 233.3 305.3 188.4 Oral Cavity and Pharynx 98 68 30 10.5 17.1 5.6 34 25 9 3.8 6.9 1.7 Lip * * 0 * * 0.0 * * 0 * * 0.0 Tongue 22 15 7 2.3 3.8 1.3 * * * * * * Salivary Gland * * * * * * * 0 * * 0.0 * Floor of Mouth 12 8 * 1.2 1.8 * * * 0 * * 0.0 Gum and Other Mouth 12 7 * 1.3 1.7 * * * * * * * Nasopharynx * * * * * * * * 0 * * 0.0 Tonsil 17 15 * 1.7 3.5 * * * 0 * * 0.0 Oropharynx 7 7 0 0.8 1.8 0.0 * * * * * * Hypopharynx 12 8 * 1.3 2.1 * * * 0 * * 0.0 Other Oral Cavity and Pharynx 7 * * 0.7 * * 10 7 * 1.1 1.8 * Digestive System 991 539 452 117.8 156.6 91.0 485 272 213 59.3 82.2 43.8 Esophagus 58 37 21 6.7 10.2 4.2 36 26 10 4.2 7.6 1.9 Stomach 89 52 37 10.7 15.7 7.5 54 30 24 6.7 9.7 4.9 Small Intestine 36 21 15 4.2 5.7 3.0 7 * * 0.8 * * Colon and Rectum 528 261 267 63.6 78.9 53.8 190 97 93 23.7 31.2 19.2 Colon excluding Rectum 399 193 206 48.4 59.6 41.6 170 86 84 21.3 28.1 17.5 Cecum 97 43 54 11.6 13.1 10.9 † † † † † † Appendix * * * * * * † † † † † † Ascending Colon 88 45 43 10.8 14.1 8.8 † † † † † † Hepatic Flexure 19 13 6 2.3 4.1 1.2 † † † † † † Transverse Colon 36 18 18 4.4 5.4 3.7 † † † † † † Splenic Flexure 21 11 10 2.7 3.5 2.2 † † † † † † Descending Colon 28 12 16 3.4 3.8 3.2 † † † † † † Sigmoid Colon 88 41 47 10.6 12.4 9.3 † † † † † † Large Intestine, NOS 19 9 10 2.3 2.8 2.0 † † † † † † Rectum and Rectosigmoid Junction 129 68 61 15.2 19.3 12.2 20 11 9 2.4 3.2 1.8 Rectosigmoid Junction 42 28 14 4.9 7.4 3.0 † † † † † † Rectum 87 40 47 10.3 11.9 9.2 † † † † † † Anus, Anal Canal and Anorectum 18 11 7 2.1 2.8 1.4 * * 0 * * 0.0 Liver and Intrahepatic Bile Duct 92 68 24 10.0 17.2 4.6 67 45 22 7.7 11.7 4.5 Liver 88 66 22 9.5 16.6 4.2 56 39 17 6.3 10.0 3.4 Intrahepatic Bile Duct * * * * * * 11 6 * 1.4 1.8 * Gallbladder 11 * 8 1.3 * 1.6 * 0 * * 0.0 * Other Biliary 13 9 * 1.6 2.6 * 6 * * 0.8 * * Pancreas 133 72 61 16.3 21.4 12.6 114 61 53 14.1 18.1 11.1 Retroperitoneum * * * * * * * * 0 * * 0.0 Peritoneum, Omentum and Mesentery * 0 * * 0.0 * * 0 * * 0.0 * Other Digestive Organs 7 * * 0.7 * * * * * * * * Respiratory System 799 455 344 95.1 133.9 69.1 569 343 226 69.0 102.6 46.4 Nose, Nasal Cavity and Middle Ear 7 7 0 0.9 2.1 0.0 0 0 0 0.0 0.0 0.0 Larynx 65 48 17 7.5 13.9 3.3 19 14 * 2.3 4.1 * Lung and Bronchus 718 394 324 85.7 116.2 65.2 550 329 221 66.7 98.5 45.3 Pleura 6 * * 0.7 * * 0 0 0 0.0 0.0 0.0 Trachea, Mediastinum and Other Respiratory Organs * * * * * * 0 0 0 0.0 0.0 0.0 Bones and Joints 11 * 6 1.2 * 1.1 8 * * 0.8 * * Soft Tissue including Heart 33 16 17 3.6 4.2 3.2 11 * 7 1.3 * 1.5 Skin excluding Basal and Squamous 15 7 8 1.6 1.7 1.5 * * * * * * Melanoma of the Skin * 0 * * 0.0 * * 0 * * 0.0 * Other Non-Epithelial Skin 11 7 * 1.1 1.7 * * * 0 * * 0.0 Breast 629 6 623 70.3 1.4 120.2 181 0 181 20.9 0.0 35.5
African-American Incidence Rate Mortality Rate Total Male Female Total Male Female Total Male Female Total Male Female Female Genital System 257 0 257 28.7 0.0 49.6 103 0 103 12.5 0.0 21.0 Cervix Uteri 68 0 68 7.0 0.0 12.4 23 0 23 2.6 0.0 4.5 Corpus and Uterus, NOS 110 0 110 12.7 0.0 21.8 34 0 34 4.0 0.0 6.9 Corpus Uteri 104 0 104 12.0 0.0 20.6 16 0 16 2.0 0.0 3.4 Uterus, NOS 6 0 6 0.7 0.0 1.2 18 0 18 2.0 0.0 3.5 Ovary 57 0 57 6.6 0.0 11.2 41 0 41 5.2 0.0 8.6 Vagina 8 0 8 0.9 0.0 1.5 * 0 * * 0.0 * Vulva 13 0 13 1.4 0.0 2.4 * 0 * * 0.0 * Other Female Genital Organs * 0 * * 0.0 * * 0 * * 0.0 * Male Genital System 935 935 0 111.6 274.7 0.0 144 144 0 18.6 50.3 0.0 Prostate 925 925 0 110.5 271.8 0.0 143 143 0 18.4 50.0 0.0 Testis * * 0 * * 0.0 0 0 0 0.0 0.0 0.0 Penis * * 0 * * 0.0 * * 0 * * 0.0 Other Male Genital Organs 0 0 0 0.0 0.0 0.0 0 0 0 0.0 0.0 0.0 Urinary System 250 151 99 29.6 43.9 20.0 52 29 23 6.4 8.7 4.8 Urinary Bladder 106 68 38 13.0 21.3 7.9 26 15 11 3.3 4.9 2.3 Kidney and Renal Pelvis 138 80 58 15.8 21.6 11.5 26 14 12 3.1 3.9 2.5 Ureter * * 0 * * 0.0 0 0 0 0.0 0.0 0.0 Other Urinary Organs * * * * * * 0 0 0 0.0 0.0 0.0 Eye and Orbit * * 0 * * 0.0 0 0 0 0.0 0.0 0.0 Brain and Other Nervous System 44 19 25 4.8 4.7 4.9 28 11 17 3.3 3.0 3.5 Brain 32 12 20 3.4 2.8 3.9 † † † † † † Cranial Nerves Other Nervous System 12 7 * 1.4 1.9 * † † † † † † Endocrine System 66 14 52 7.0 3.5 9.7 8 * * 0.9 * * Thyroid 58 11 47 6.1 2.8 8.8 * * * * * * Other Endocrine including Thymus 8 * * 0.8 * * 6 * * 0.6 * * Lymphoma 188 96 92 20.8 25.0 17.9 44 22 22 5.2 6.9 4.2 Hodgkin’s Lymphoma 25 10 15 2.5 2.1 2.9 * * * * * * Hodgkin’s - Nodal 24 10 14 2.4 2.1 2.7 † † † † † † Hodgkin’s - Extranodal * 0 * * 0.0 * † † † † † † Non-Hodgkin’s Lymphoma (NHL) 163 86 77 18.2 22.9 15.1 41 20 21 4.9 6.3 4.1 NHL - Nodal 117 60 57 13.1 16.3 11.1 † † † † † † NHL - Extranodal 46 26 20 5.1 6.6 4.0 † † † † † † Myeloma 103 52 51 12.5 15.5 10.6 64 36 28 7.9 10.9 5.9 Leukemia 110 66 44 12.5 18.9 8.4 56 34 22 6.6 10.3 4.3 Lymphocytic Leukemia 46 31 15 5.3 8.9 2.8 20 11 9 2.3 3.3 1.7 Acute Lymphocytic Leukemia 9 * 7 0.9 * 1.3 * * * * * * Chronic Lymphocytic Leukemia 32 25 7 3.8 7.5 1.4 15 8 7 1.9 2.7 1.4 Other Lymphocytic Leukemia * * * * * * 0 0 0 0.0 0.0 0.0 Myeloid and Monocytic Leukemia 50 30 20 5.8 8.5 4.0 18 13 * 2.1 3.6 * Acute Myeloid Leukemia 26 17 9 3.0 5.0 1.8 15 11 * 1.7 3.2 * Acute Monocytic Leukemia 0 0 0 0.0 0.0 0.0 0 0 0 0.0 0.0 0.0 Chronic Myeloid Leukemia 18 10 8 2.1 2.7 1.6 * * * * * * Other Myeloid/Monocytic Leukemia 6 * * 0.7 * * 0 0 0 0.0 0.0 0.0 Other Leukemia 14 * 9 1.4 * 1.6 18 10 8 2.3 3.4 1.6 Other Acute Leukemia * * * * * * 7 * * 0.9 * * Aleukemic, Subleukemic and NOS 10 * 8 1.0 * 1.4 11 6 * 1.4 2.0 * Miscellaneous 84 35 49 10.0 10.3 9.7 139 68 71 16.3 19.6 13.9 13 Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) standard. † Not reported * Statistic not displayed due to fewer than 6 cases. Source: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
Page 1: Cancer Statistics in Metropolitan D
Page 4 and 5: Metropolitan Detroit Cancer Surveil
Page 6 and 7: Population by Age, Gender and Race/
Page 8 and 9: MDCSS Authority to Collect Cancer I
Page 10 and 11: All Races Cancer Incidence, Mortali
Page 12 and 13: Caucasian Cancer Incidence, Mortali
Page 16 and 17: Survival Analysis of Prostate Cance
Page 18 and 19: Survival Analysis of Lung Cancer by
Page 20 and 21: 2007 Annual Scientific Conference o
Page 22 and 23: Cancer in the Arab and Chaldean Ame
Page 24 and 25: Arsenic and Cancer of the Urinary B
Page 26 and 27: External Investigators: Use of MDCS
Page 28 and 29: 26 Assessing Smoking and Drinking i
Page 30 and 31: 28 Hill DA, Wang SS, Cerhan JR, Dav
Page 32 and 33: Affiliations and Acknowledgments ST
Page 34 and 35: Appendix A Michigan Public Health C
Page 36 and 37: Appendix A (continued) Health Insur
Page 38: Metropolitan Detroit Cancer Surveil

Cancer Statistics - Karmanos Cancer Institute

Create successful ePaper yourself

Delete template?

Save as template?